South Korea: Seeking IP protection for medical devices
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

South Korea: Seeking IP protection for medical devices

Sponsored by

hanolip-400px.png
piotr-chrobot-m0wbgfrtxqu-unsplash.jpg

Recently, the Korean medical devices market has been growing notably. According to a 2019 Annual Report by the Korea Medical Devices Industry Association, the Korean domestic market has grown at a CAGR (Compound Annual Growth Rate) of 8% during the last five years (2014 to 2018). The global medical devices market also exhibits a rising trend; Fortune Business Insight has forecasted a CAGR of 5.3% from 2018 to 2025. In view of a growing geriatric population, the prevalence of lifestyle-related diseases, and rising demand for new innovative devices and personalised healthcare services, the future medical devices market is expected to show steady growth.

In order to foster the domestic medical devices industry, the Korean government has recently introduced a new law, Development of the Medical Device Industry and Innovative Medical Device Support Act, effective from May 5, 2019. This new act is expected to further promote the development of new innovative technologies and the emergence of innovator companies in this field.

The recent statistical analysis of the Korean patent filings by the Korean Intellectual Property Office (KIPO) shows a similar trend. In the last 10 years (2009 to 2018), the number of patent filings in the field of medical devices has grown to 76,646 in total, with a steep growth rate, i.e. CAGR of 6.82%, which exceeds five times the growth rate (CAGR of 1.3%) of patent filings in the entire field.

KIPO analysis indicates that there exists a large portion of patent applications directed to medical supplies, surgical/treatment instruments, and bio-measurement devices. The number of patent filings in the fields of healthcare information devices and bio-measurement devices has increased significantly.

According to the KIPO analysis, "healthcare information devices" are witnessing a boom due to the increased use of medical big data, the development of cloud-connected mobile healthcare platforms, and the emergence of AI-based medical services. In addition, "bio-measurement devices" are driven by the increasing demand for automated, miniaturised devices along with ICT-integration due to the transition of medical paradigm from treatment and care to prevention.

Domestic filers are very active, and Samsung Electronics and Samsung Medison ranked in the top two.

Needless to say, building a strategic patent portfolio is crucial to protecting a medical device company's core technology. In order to develop a strategic patent portfolio, it is necessary to include various claims covering the entire device or system, as well as key components, control systems, disposables, apps, methods of use, and any other valuable aspects of the invention.

In Korea, it is possible to use various claim formats; not only "a product" claim such as an equipment, system, apparatus, instrument, device, component, etc., but also a claim directed to "a method" of using or operating a medical device.

There is no particular restriction on pursuing a medical device itself, since a medical device for use in a surgery, treatment, or diagnosis method practised on a human being is patent-eligible in Korea.

Furthermore, a method of operating a medical device or a measurement method using a medical device is also patent-eligible, unless such method includes a substantial medical activity (i.e. a surgical, therapeutic, or diagnostic methods practised on a human body) or an interaction between the human body and the medical device, wherein the interaction has a direct and non-transient effect on the human body.

In addition, even a diagnostic method using a medical device can be protected, as long as it is clearly interpreted as a method for processing information on a computer, and a clinical judgment by a medical practitioner is not involved (e.g. a method for predicting cancer, comprising performing artificial intelligence algorithms in a medical device).

As additional strategies, utility model or design registrations can also provide protection for medical devices in Korea. Relatively speaking it is easier, quicker and less expensive to obtain a utility model or design registration than a patent. In order to provide a perfect protection barrier, it is advisable to consider various ways of protection for innovative medical devices.

Further, considering the tendency for medical devices to be commercialised much faster than other medical products, such as pharmaceutical products, it may be important to shorten the time to grant by using accelerated examination.

Korean patent trend in medical devices (2009-2018)

korea-chart.png


Domestic applicants (Top 5)

Foreign applicants (Top 5)

1

SAMSUNG ELECTRONICS CO., LTD

KIMBERLY-CLARK WORLDWIDE, INC.

2

SAMSUNG MEDISON CO.,LTD.

UNI-CHARM CO., LTD.

3

Industry-Academic Cooperation Foundation, Yonsei University

SYNTHES GmbH

4

Seoul National University R&DB Foundation

SIEMENS AKTIENGESELLSCHAFT

5

Korea University Research and Business Foundation

F. HOFFMANN-LA ROCHE AG




Min Son

Partner, Hanol IP & Law

E: minson@hanollawip.com



HANOL Intellectual Property & Law

6th Floor, Daemyung Tower, 135, Beobwon-ro, Songpa-gu

Seoul, 05836

Republic of Korea

Tel: +82 2 942 1100 

Fax: +82 2 942 2600

hanol@hanollawip.com

www.hanollawip.com

more from across site and ros bottom lb

More from across our site

Partners and other senior leaders must step up if they want diverse talent at their firms to thrive
European and US counsel reveal why they are (or aren't) concerned about patent quality and explain how external counsel can help
Firms such as Bird & Bird and Taylor Wessing have reported rising profits and highlighted the role of high-profile IP disputes and hires
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Lawyers in the corporate and IP practices discuss where the firm can steal a march on competitors, its growth plans in London, and why deal lawyers are ‘concertmasters’
Kathleen Gaynor, DEI specialist at Phillips Ormonde Fitzpatrick, says deliberate actions can help law firms reach diversity goals
Scott McKeown, who moved to Wolf Greenfield one year ago, says the change has helped him tap into life sciences work and advise more patent owners
The winners of our Asia-Pacific Awards 2024 will be revealed during a ceremony in Malaysia on September 26
Zach Piccolomini of Wolf Greenfield explains how to maximise your IP portfolio’s value while keeping an eye on competitors
Witnesses at a Congressional hearing debated whether reforming the ITC is necessary and considered what any changes should look like
Gift this article